NEW YORK (GenomeWeb) – Invivoscribe said today that it has inked a long-term collaboration with Illumina to develop and commercialize in vitro diagnostic assays for Illumina's MiSeqDx next-generation sequencing platform.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.